We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.3B
AUM Growth
+$200M
Cap. Flow
-$904M
Cap. Flow %
-5.54%
Top 10 Hldgs %
25.94%
Holding
1,279
New
291
Increased
178
Reduced
593
Closed
139

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$826M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$316M
3
AVGO icon
Broadcom
AVGO
+$129M
4
MDT icon
Medtronic
MDT
+$105M
5
DD icon
DuPont de Nemours
DD
+$84.6M

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$96M
2
MMM icon
3M
MMM
+$81.6M
3
MSFT icon
Microsoft
MSFT
+$79M
4
MRK icon
Merck
MRK
+$73.5M
5
CELG
Celgene Corp
CELG
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 17.17%
2 Healthcare 14.63%
3 Financials 13.12%
4 Communication Services 11.69%
5 Consumer Staples 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1226
United Therapeutics
UTHR
$23.1B
– –
-29,041
Closed -$2.35M
VCYT icon
1227
Veracyte
VCYT
$3.8B
– –
-34,100
Closed -$826K
VET icon
1228
Vermilion Energy
VET
$1.66B
– –
-158,655
Closed -$2.68M
VNDA icon
1229
Vanda Pharmaceuticals
VNDA
$302M
– –
-8,600
Closed -$117K
XNCR icon
1230
Xencor
XNCR
$1.55B
– –
-14,900
Closed -$510K
ZUMZ icon
1231
Zumiez
ZUMZ
$339M
– –
-1,376
Closed -$41K
TXNM
1232
TXNM Energy Inc
TXNM
$5.94B
– –
-1,781
Closed -$92K
ITCI
1233
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-65,700
Closed -$493K
RVNC
1234
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-40,000
Closed -$550K
EGRX
1235
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-6,900
Closed -$389K
TUP
1236
DELISTED
Tupperware Brands Corporation
TUP
– –
-86,316
Closed -$1.38M
ICPT
1237
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-14,240
Closed -$913K
LTRPA
1238
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
– –
-2,037
Closed -$19K
NATI
1239
DELISTED
National Instruments Corp
NATI
– –
-230,000
Closed -$9.65M
SPPI
1240
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-67,400
Closed -$597K
ACOR
1241
DELISTED
Acorda Therapeutics
ACOR
– –
-152
Closed -$55K
BBBY
1242
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-1,775
Closed -$18K
CNCE
1243
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-7,400
Closed -$46K
AERI
1244
DELISTED
Aerie Pharmaceuticals
AERI
– –
-12,400
Closed -$252K
CCXI
1245
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-16,500
Closed -$108K
ENDP
1246
DELISTED
Endo International plc
ENDP
– –
-83,400
Closed -$266K
RDUS
1247
DELISTED
Radius Health, Inc.
RDUS
– –
-15,800
Closed -$411K
EPZM
1248
DELISTED
Epizyme, Inc
EPZM
– –
-121,500
Closed -$1.24M
ISBC
1249
DELISTED
Investors Bancorp, Inc.
ISBC
– –
-78,100
Closed -$894K
DRNA
1250
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-23,000
Closed -$349K
48 49
50
51 52

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q4 2019 Portfolio in Review

As of Q4 2019, DekaBank Deutsche Girozentrale held 1,279 positions worth $16.3B, up 1.2% from $16.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

DekaBank Deutsche Girozentrale withdrew a net $904M in Q4 2019, closing 139 positions and reducing 593 holdings. Its most notable exit was Celgene Corp, an estimated $65.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, DekaBank Deutsche Girozentrale opened a new position in Linde worth $871M.

  • DekaBank Deutsche Girozentrale's largest Q4 2019 buy was Linde: 4,097,371 shares worth $871M.
  • DekaBank Deutsche Girozentrale added most to Phillips 66 in Q4 2019, an estimated $73.3M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2019 reduction was CME Group, cutting an estimated $96M.
  • DekaBank Deutsche Girozentrale fully exited Celgene Corp in Q4 2019, selling an estimated $65.4M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $16.3B portfolio in Q4 2019.
  • DekaBank Deutsche Girozentrale opened 291 new positions and closed 139 in Q4 2019.
  • DekaBank Deutsche Girozentrale's portfolio value rose 1.2% quarter-over-quarter to $16.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.